Virgin Orbit's "Cosmic Girl," a retrofitted Boeing 747 plane, is scheduled for a horizontal launch into orbit Monday night from the United Kingdom's Spaceport Cornwall. The mission, dubbed Start Me Up, is the first orbital launch in both the UK and Western Europe. It's also the culmination of a yearslong effort by the country to enter the modern space race. 

Cosmic Girl has a payload of nine small satellites from several customers, including the U.S. Naval Research Laboratory, the U.K. Ministry of Defence, and the government of Oman. 

Don't expect the same fanfare as some recent space launches. Horizontal space launches are generally more seamless. Cosmic Girl will take off like a normal plane, fly to around 35,000 feet above the southern coast of Ireland, and then deploy the LauncherOne rocket.

The LauncherOne is a so-called air-launched rocket. Launched from a carrier aircraft at high altitudes, the rocket is able to deliver small payloads of satellites into orbit. Virgin Orbit developed the concept over years, and started putting it into use in 2021. 

Ian Annett, deputy chief executive at the UK Space Agency, has heralded the launch as an "iconic moment" — though it's not technically England's first. The agency completed a mission, called the Black Arrow, back in 1971, but the launch actually took place in Australia. 

This is Virgin Orbit's sixth launch. The private space company had initially planned six for 2022, but lowered its forecast amid financial troubles. The company recently announced plans to raise $25 million to refill its shrinking cash reserves. 

Share:
More In Science
As U.S. Opioid Crisis Worsens, Price of Life-Saving Drug Naloxone Skyrockets
Jill Wagner and Baker Machado break down the state of the Opioid Crisis in the U.S. The CDC reported a 30% increase in overdose deaths from 2020 to 2021, but in recent months pharmaceutical companies have drastically raised the price of Naloxone or 'Narcan,' affecting the response of community harm prevention groups.
Regeneron Joins Battle Against COVID-19, Releases Stats on New COVID Treatment
The world hit a grim milestone on Monday, with COVID-19 cases surpassing a quarter of a billion worldwide. As cases increase, the fight to beat the virus continues as well, with a number of medical breakthroughs coming out over the last few months in the form of pills from Pfizer and Merck. Regeneron is now the latest company to join the fight, recently releasing new data on a covid antibody cocktail. Professor Peter Pitts, former FDA Associate Commissioner and the founder of the Center for Medicine in the Public Interest breaks down the differences between the 3 treatments and why vaccines are still among the fire line of defense.
Legal Questions Swirl as States Push Back Against Biden COVID Vaccine Mandate
The Biden Administration's mandate for COVID vaccinations by large employers has been put on hold by federal courts as GOP-led states and some businesses push back on the order's legality. Jonathan Adler, a law professor at Case Western Reserve University, joined Cheddar to discuss the legal challenges to implementing such mandates through OSHA (Occupational Safety and Health Administration). "Certainly expanding vaccinations is a good thing, and as vaccination rates go up that's better for all of us," Adler said. "But there are some legal questions about whether or not it's appropriate to use a law about occupational safety and health as the means to do that."
What COVID-19 Vaccines for Kids Might Mean for Fight Against Pandemic
Dr. Robert Frenck, an infectious disease specialist at Cincinnati Children's Hospital, joined Cheddar to talk about the significance of children ages 5-11 being authorized to receive COVID-19 vaccinations. He also discussed schools being cleared to administer vaccines and noted the importance of meeting people where they are rather than forcing them to find the shots. Frenck also said he expects that children under 5 years old will begin getting vaccinations sometime in spring.
Everything You Need to Know About Child Covid-19 Vaccines
A CDC advisory committee as unanimously voted to recommend the Pfizer Covid-19 vaccine in children ages 5 to 11. Dr. Amesh Adalja, Infectious Disease Specialist and Senior Scholar at Johns Hopkins Center for Health Security, joined Cheddar News to discuss.
Load More